Bridge Pharmaceuticals, the leading preclinical Contract Research Organization in Asia, announced that its preclinical testing laboratory in Zhongguancun Life Science Park in Beijing, China has completed the first of two validation phases of all instrumentation, software and air handling and BMS systems. This state of the art facility, one of the largest and most advanced vivariums in China, is currently the only preclinical laboratory in China to have US level GLP validated systems and software.
